Why the study?
In the endgame of global polio eradication, serosurveillance is essential to monitor vulnerability to poliomyelitis outbreaks, but prior pseudovirus neutralization tests with wild-type strains showed poor correlation with conventional tests for type 1.
Answers are grounded in this paper and cite their sources.
A pseudovirus neutralization test using Sabin strain capsid proteins correlates highly with conventional tests and offers a safer alternative for poliovirus serosurveillance without requiring infectious viruses.
In the endgame of global polio eradication, serosurveillance is essential to monitor each country’s vulnerability to poliomyelitis outbreaks. Previously, we developed pseudovirus poliovirus (PV) neutralization test (pPNT) with type 1, 2, and 3 PV pseudovirus (PVpv), which possess a luciferase-encoding PV replicon in the capsids of wild-type strains (PVpv[WT]), showing that pPNT with type 2 and 3 PVpv(WT) but not type 1 shows high correlation with the conventional PV neutralization test (cPNT) performed with vaccine strains. Here, we analyse the antigenicity of PVpv(WT) and PVpv with capsid proteins of Sabin vaccine strains (PVpv[Sabin]) in human serum. Type 2 and 3 PVpv(WT) and PVpv(Sabin) show similar antigenicity in the analysed set of human sera in contrast to type 1 PVpv. The levels of PVpv(Sabin) infection (%), including about 70% of PVpv infection (%) measured in the presence of human serum diluted to the cPNT titre, serve as the optimal threshold values for pPNT (5% for type 1 and 2, 10% for type 3) to show high correlation with cPNT results. Our results suggest that pPNT with PVpv(Sabin) could serve as an alternative to cPNT and provide a rationale for pPNT threshold values.
No takes yet. Share an insight, caveat, or question.
Arita et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: